Asia-Pacific Point-of-Care Testing (POCT) Market to See Astonishing Growth by 2019-2026


Posted May 14, 2021 by eathaneathan

Point-of-care testing (POCT) market is characterized as a testing which can be done in close proximity to the patient where a medical decision can be made immediately including the results and monitoring.

 
Point-of-care testing (POCT) market is characterized as a testing which can be done in close proximity to the patient where a medical decision can be made immediately including the results and monitoring. Point-of-care testing (POCT) is also called with-patient testing and allows physicians to accurately measure real-time, lab-quality diagnostic results within less than minutes as compared to hours. It ensures patients to receive the most effective and efficient care when and wherever needed. Additionally, point-of-care testing (POCT) enables staff to make rapid decisions of treatments when diagnosing patients’ condition and the point-of-care testing (POCT) simplifying the testing process.

The major factors driving the growth of the point-of-care testing (POCT) market are increasing number of liver, kidney diseases and emerging technologies of point-of-care testing (POCT). While the factor which affects the point-of-care testing (POCT) market from growing are high cost of equipment and stringent government regulations.

Asia-Pacific point-of-care testing (POCT) market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 10.2% in the forecast period of 2020 to 2027 and is expected to reach USD 6,425.57 million by 2027, from USD 2983.05 million in 2019.

This Asia-Pacific Point-of-Care Testing (POCT) Market research report intensely analyses the potential of the market with respect to current scenario and the future prospects by considering several industry aspects of Cardinal Health industry. The report also recognizes and analyses the rising trends along with major drivers, challenges and opportunities in the market. This Asia-Pacific Point-of-Care Testing (POCT) Market report provides major statistics on the market status of global and regional manufacturers and is a helpful source of assistance and direction for companies and individuals interested in Healthcare industry. The company profiles of all the chief and dominating market players and brands who are taking steps such as product launches, joint ventures, mergers and acquisitions are mentioned in the report.

Market Drivers and Restraints:

On the basis of product, the point-of-care testing (POCT) market is segmented into glucose monitoring products, cardiometabolic testing products, infectious disease testing products, pregnancy and fertility testing products, tumor/cancer marker testing products, urinalysis testing products, cholesterol testing products, hematology testing products, drugs-of-abuse testing products, fecal occult testing products, rapid coagulation testing and other POC products.

On the basis of application, the point-of-care testing (POCT) market is segmented into blood transfusion, cardiac monitoring, coagulation, blood glucose, haematology, non- invasive SPO2 monitoring, non- invasive PCO2 monitoring, whole blood analysis, vital sign monitoring and others.

On the basis of platform, the point-of-care testing (POCT) market is segmented into lateral flow assays/immunochromatography tests, dipsticks, microfluidics, molecular diagnostics and immunoassays. In 2020, the lateral flow assays/immunochromatography tests segment in point-of-care testing (POCT) market is expected to grow as lateral flow assays are known as the popular type of assay and have been recently attracted considerable interest because of its potential to provide instantaneous diagnosis directly to the patients.

On the basis of prescription mode, the point-of-care testing (POCT) market is segmented into prescription-based testing and OTC testing. In 2020, the prescription-based testing segment in point-of-care testing (POCT) market is expected to grow due to increases demand of healthcare delivery which are aimed at delivering less costly care closer to the patient’s home.

The major players covered in the Asia-Pacific Point-of-Care Testing (POCT) Market

The major players covered in the report Abbott, F. Hoffmann-La Roche Ltd, BD, Siemens Healthcare Private Limited, Bio-Rad Laboratories, Inc., Danaher, Sekisui Diagnostics, Trinity Biotech, bioMérieux SA, EKF Diagnostics, AccuBioTech Co., Ltd., Instrumentation Laboratory, Beckman Coulter, Inc., PTS Diagnostics, Nova Biomedical, Chembio Diagnostics Systems, Inc., Quidel Corporation and Sienco, Inc among others domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Major Toc Of The Report Asia-Pacific Point-of-Care Testing (POCT) Market

chapter One:   Asia-Pacific Point-of-Care Testing (POCT) Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three:   Asia-Pacific Point-of-Care Testing (POCT) Market Competition, by Players

Chapter Four:  Asia-Pacific Point-of-Care Testing (POCT) Market Size by Regions

Chapter Five:  Asia-Pacific Point-of-Care Testing (POCT) Market Revenue by Countries

Chapter Six:  Asia-Pacific Point-of-Care Testing (POCT) Market Revenue by Countries

Chapter Seven:  Asia-Pacific Point-of-Care Testing (POCT) Market Revenue by Countries

Chapter Eight:  Asia-Pacific Point-of-Care Testing (POCT) Market Revenue by Countries

Key Report Highlights
Comprehensive pricing analysis based on different product types and regional segments
Market size data in terms of revenue and sales volume
Deep insights about regulatory and investment scenarios of the Asia-Pacific Point-of-Care Testing (POCT) Market
Analysis of market effect factors and their impact on the forecast and outlook of the global   Asia-Pacific Point-of-Care Testing (POCT) Market
The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the Asia-Pacific Point-of-Care Testing (POCT) Market
A roadmap of growth opportunities available in the Asia-Pacific Point-of-Care Testing (POCT) Market with the identification of key factors
The exhaustive analysis of various trends of the Asia-Pacific Point-of-Care Testing (POCT) Market to help identify market developments
Key Questions Answered in Report:
What is the key to the Asia-Pacific Point-of-Care Testing (POCT) Market?
What will the Asia-Pacific Point-of-Care Testing (POCT) Market Demand and what will be Growth?
What are the latest opportunities for Asia-Pacific Point-of-Care Testing (POCT) Market in the future?
What are the strengths of the key players?

Browse Related Reports@
Blood Screening Market
Metabolic Testing Market
Transfection Technologies Market
About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research 

Tel: +1-888-387-2818

Email: [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Data Bridge Market Research 
Country United Kingdom
Categories Health
Last Updated May 14, 2021